Literature DB >> 16731133

Limitations of EuroSCORE for measurement of risk-stratified mortality in aortic arch surgery using selective cerebral perfusion: is advanced age no longer a risk?

Kaoru Matsuura1, Hitoshi Ogino, Hitoshi Matsuda, Kenji Minatoya, Hiroaki Sasaki, Toshikatsu Yagihara, Soichiro Kitamura.   

Abstract

BACKGROUND: The European system for cardiac operative risk evaluation (EuroSCORE) is a risk stratification tool for perioperative mortality of cardiothoracic surgery that was developed in Europe and validated in North America in more than 500,000 patients. The operative mortality of aortic arch surgery has been improved by various novel operative techniques and adjuncts, whereas the number of such procedures for elderly patients has recently been increasing. The aim of this study was to examine the usefulness of the EuroSCORE, and our modification of it regarding age, in predicting mortality after aortic arch repair performed with selective cerebral perfusion.
METHODS: We reviewed 358 consecutive patients with a mean age of 69 +/- 10 years undergoing aortic arch repair with selective cerebral perfusion between January 1993 and February 2004. Observed in-hospital mortality was compared with predicted mortality as determined by both additive and logistic EuroSCOREs. We also evaluated a version of the EuroSCORE modified for age, which was obtained by subtracting the contribution of age from the original EuroSCORE. Score validities were assessed by calculating the areas under receiver operating characteristic curves.
RESULTS: Overall hospital mortality was 6.2% compared with 7.7% (additive EuroSCORE) and 11.8% (logistic EuroSCORE). Area under the receiver operating characteristic curve was 0.58 for the additive EuroSCORE and 0.58 for the logistic EuroSCORE as well. The overall age-unrelated EuroSCOREs were 5.1% (additive) and 5.2% (logistic), respectively, and areas under the receiver operating characteristic curve were 0.70 for additive and 0.69 for logistic.
CONCLUSIONS: The original additive and logistic EuroSCOREs overpredicted mortality in this patient group, whereas the age-unrelated EuroSCORE was better in predicting mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16731133     DOI: 10.1016/j.athoracsur.2006.01.018

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Risk prediction of cardiovascular surgery in Japanese patients.

Authors:  Takahiro Nishida; Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-09-14

2.  Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement.

Authors:  Kyriakos Spiliopoulos; Vasilis Bagiatis; Oliver Deutsch; Bernhard M Kemkes; Nikolaos Antonopoulos; Dimos Karangelis; Ayman Haschemi; Brigitte Gansera
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-29

Review 3.  Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery.

Authors:  Alexandre Mebazaa; Antonis A Pitsis; Alain Rudiger; Wolfgang Toller; Dan Longrois; Sven-Erik Ricksten; Ilona Bobek; Stefan De Hert; Georg Wieselthaler; Uwe Schirmer; Ludwig K von Segesser; Michael Sander; Don Poldermans; Marco Ranucci; Peter C J Karpati; Patrick Wouters; Manfred Seeberger; Edith R Schmid; Walter Weder; Ferenc Follath
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

4.  The novel EuroSCORE II algorithm predicts the hospital mortality of thoracic aortic surgery in 461 consecutive Japanese patients better than both the original additive and logistic EuroSCORE algorithms.

Authors:  Takahiro Nishida; Hiromichi Sonoda; Yasuhisa Oishi; Yoshihisa Tanoue; Atsuhiro Nakashima; Yuichi Shiokawa; Ryuji Tominaga
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-23

5.  Evaluation of the reliability of the EuroSCORE risk analysis prediction in high-risk older patients undergoing CABG.

Authors:  H Iyem
Journal:  Cardiovasc J Afr       Date:  2009 Nov-Dec       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.